Literature DB >> 12135833

Vaccines for Proteus mirabilis in urinary tract infection.

Xin Li1, Harry L T Mobley.   

Abstract

Proteus mirabilis is a documented cause of urinary tract infection (UTI) in the complicated urinary tract. Urease-mediated urea hydrolysis is responsible for both virulence of the organism and the ability to cause urolithiasis. A urease-negative mutant of P. mirabilis is unable to initiate stone formation and colonizes the kidney at a significantly lower rate. The considerable pathology caused by P. mirabilis warrants the development of a vaccine. We have initiated the advancement of vaccine studies and have determined that the MR/P fimbria, a surface adhesin of P. mirabilis, is a promising vaccine candidate. Successful vaccination would be expected both to prevent colonization by P. mirabilis and urolithiasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135833     DOI: 10.1016/s0924-8579(02)00102-4

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  14 in total

1.  Metabolic versatility of prokaryotes for urea decomposition.

Authors:  Robert P Hausinger
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 2.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 3.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

4.  Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.

Authors:  Greta R Nielubowicz; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

5.  The effect of type-1 fimbrial immunization on gut pathophysiological response in rats infected with Salmonella enterica subsp. enterica serovar Typhimurium.

Authors:  Amrisha Verma; Sulagna Basu; Sujata Ghosh; S Majumdar; N K Ganguly
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

6.  Comparison of virulence genes in Proteus species isolated from human and pet turtle.

Authors:  H N K S Pathirana; B C J De Silva; S H M P Wimalasena; S Hossain; G J Heo
Journal:  Iran J Vet Res       Date:  2018       Impact factor: 1.376

7.  Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis.

Authors:  Praveen Alamuri; Martin Löwer; Jan A Hiss; Stephanie D Himpsl; Gisbert Schneider; Harry L T Mobley
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

8.  Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.

Authors:  Angela M Jansen; Virginia Lockatell; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

9.  Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.

Authors:  Greta R Nielubowicz; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

10.  Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.

Authors:  Praveen Alamuri; Kathryn A Eaton; Stephanie D Himpsl; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.